The rising prevalence in GLP-1 agonists for metabolic health has generated a debate about delivery routes : skin-applied devices versus tablets . Usually , GLP-1 therapies were only available in oral https://maeclsj874584.bcbloggers.com/39789746/glp-1-transdermal-delivery-systems-vs-pills-which-suitable-for-you